Why the study?
What are the clinical outcomes and treatment adherence at 12 months in patients treated with single antiplatelet therapy directly after PCI for NSTE-ACS?
What are the clinical outcomes and treatment adherence at 12 months in patients treated with single antiplatelet therapy directly after PCI for NSTE-ACS?
This study evaluates 12-month clinical outcomes and adherence for single antiplatelet therapy immediately following PCI in NSTE-ACS patients.
Graphical AbstractClinical outcomes and treatment adherence during 12 months follow-up. *Second bleeding event in same patient. PCI, percutaneous coronary intervention; TVR, target vessel revascularization.
No takes yet. Share an insight, caveat, or question.
Sangen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: